← FDA Drug Approvals (Drugs@FDA)

MOMETASONE FUROATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2024-11-22

Drug application

FDA Application #

ANDA217498

Application type

Abbreviated New Drug Application (Generic)

Brand name

MOMETASONE FUROATE

Generic name

MOMETASONE FUROATE

Active ingredients

MOMETASONE FUROATE

Dosage form

SPRAY, METERED

Route

NASAL

Marketing status

Discontinued

Sponsor

AUROBINDO PHARMA

Manufacturer

Aurohealth LLC

First approval

2024-11-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown